BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28324284)

  • 41. [Current status and perspectives on "watch and wait" strategy for rectal cancer patients after clinical complete response following neoadjuvant chemoradiation].
    Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):521-526. PubMed ID: 31238632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy.
    Yu G; Lu W; Jiao Z; Qiao J; Ma S; Liu X
    World J Surg Oncol; 2021 Oct; 19(1):305. PubMed ID: 34663341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy.
    Smith JD; Ruby JA; Goodman KA; Saltz LB; Guillem JG; Weiser MR; Temple LK; Nash GM; Paty PB
    Ann Surg; 2012 Dec; 256(6):965-72. PubMed ID: 23154394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 'Watch and wait' after chemoradiotherapy for rectal cancer.
    Mullaney TG; Lightner AL; Johnston M; Keck J; Wattchow D
    ANZ J Surg; 2018 Sep; 88(9):836-841. PubMed ID: 30047201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wait and see approach for rectal cancer with a clinically complete response after neoadjuvant concurrent chemoradiotherapy.
    Kim HJ; Song JH; Ahn HS; Choi BH; Jeong H; Choi HS; Lee YH; Kang KM; Jeong BK
    Int J Colorectal Dis; 2017 May; 32(5):723-727. PubMed ID: 27885479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "WATCH AND WAIT" STRATEGY IN RECTAL CANCER PATIENTS WITH A COMPLETE CLINICAL RESPONSE AFTER NEOADJUVANT CHEMORADIATION THERAPY: A SINGLE-CENTER EXPERIENCE.
    Kokaine L; Radzina M; Liepa M; Gerina-Berzina A; Sīviņa E; Nikolajeva J; Gardovskis A; Gardovskis J; Miklaševičs E
    Exp Oncol; 2024 May; 46(1):53-60. PubMed ID: 38852052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonoperative Management for Rectal Cancer.
    Quezada-Diaz FF; Smith JJ
    Hematol Oncol Clin North Am; 2022 Jun; 36(3):539-551. PubMed ID: 35562257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation.
    Glynne-Jones R; Hughes R
    Br J Surg; 2012 Jul; 99(7):897-909. PubMed ID: 22539154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy.
    Chino A; Konishi T; Ogura A; Kawachi H; Osumi H; Yoshio T; Kishihara T; Ide D; Saito S; Igarashi M; Akiyoshi T; Ueno M; Fujisaki J
    Eur J Surg Oncol; 2018 Aug; 44(8):1247-1253. PubMed ID: 29731188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Complete Response in Patients With Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Nonoperative Management.
    Chin RI; Roy A; Pedersen KS; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Badiyan SN; Shetty AS; Henke LE; Mutch MG; Kim H
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):715-725. PubMed ID: 34653579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
    Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is Nonoperative Management of Rectal Cancer Feasible?
    Quezada-Diaz FF; Smith JJ
    Adv Surg; 2023 Sep; 57(1):141-154. PubMed ID: 37536849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases.
    Asoglu O; Tokmak H; Bakir B; Demir G; Ozyar E; Atalar B; Goksel S; Koza B; Guven Mert A; Demir A; Guven K
    Eur J Surg Oncol; 2020 Mar; 46(3):402-409. PubMed ID: 31955995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time.
    São Julião GP; Karagkounis G; Fernandez LM; Habr-Gama A; Vailati BB; Dattani M; Kalady MF; Perez RO
    Ann Surg; 2020 Jul; 272(1):138-144. PubMed ID: 30946085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
    Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-Effectiveness and Quality-Adjusted Survival of Watch and Wait After Complete Response to Chemoradiotherapy for Rectal Cancer.
    Miller JA; Wang H; Chang DT; Pollom EL
    J Natl Cancer Inst; 2020 Aug; 112(8):792-801. PubMed ID: 31930400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early results from implementation of a 'watch and wait' protocol for complete clinical response following chemoradiotherapy for rectal cancer.
    Balasuriya HD; Timon C; Entriken F; Neely D; Herron J; Tang C; Van Hazel G; Warner MW
    ANZ J Surg; 2022 Nov; 92(11):2961-2967. PubMed ID: 35841184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer.
    Beard BW; Rettig RL; Ryoo JJ; Parker RA; McLemore EC; Attaluri V
    J Am Coll Surg; 2020 Dec; 231(6):681-692. PubMed ID: 33121903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer.
    Coraglio MF; Eleta MA; Kujaruk MR; Oviedo JH; Roca EL; Masciangioli GA; Mendez G; Iseas IS
    World J Surg Oncol; 2020 Nov; 18(1):313. PubMed ID: 33256819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.